Acerca de

Program
08.45-09.20
09.20-09.30
09.30-10.00
10.00-10.15
10.15-10.45
10.45-11.00
11.00-11.20
11.20-11.40
11.40-12.10
12.10-12.30
12.30-12.40
12.40-13.40
13.40-14.10
14.10-14.40
14.40-14.50
14.50-15.10
15.10-15.30
15.30-15.45
15.45
Registration
Welcome & Introduction H.L.A. Janssen
Portal hypertension: Baveno VII and beyond Chair S. Darwish Murad
Beta blockade all patients with portal hypertension? C. Ripoll
Statins for all patients with cirrhosis? R. Maan
Treatment of hepatic encephalopathy beyond lactulose J.G. Langendonk
Secondary prophylaxis for SBP with noroxin or rifaximin R.B. Takkenberg
Discussion
Coffee break
State of the art lectures part 1 Chair M.J. Sonneveld
Porto-sinusoidal vascular disorder: a new name for an old disease P.E. Ratou
When to start and when to stop nucleo(s)tide analogues in chronic hepatitis B H.L.A. Janssen
Discussion
Lunch
State of the art lectures part 2 Chair R.J. de Knegt
Steroids in alcoholic hepatitis: yes, no or with antibiotics? A. Louvet
New pharmacological therapies for NAFLD/NASH, all diabetics with NASH on GLP-1? S. Francque
Discussion
Liver tumors Chair R.A. de Man
HCC surveillance; imaging, AFP and beyond D. Sprengers
Liver transplantation for perihilar cholangiocarcinoma: indication and outcome R.J. Porte
Discussion and closing remarks H.L.A. Janssen
Drinks